1776 Wealth’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$418K Hold
8,711
0.15% 99
2026
Q1
$320K Hold
8,711
0.13% 114
2025
Q4
$443K Buy
8,711
+189
+2% +$9.66K 0.17% 96
2025
Q3
$473K Buy
+8,522
New +$499K 0.18% 89

Other funds holding NVO

1776 Wealth's NVO Position: Q2 2026 in Review

1776 Wealth held its Novo Nordisk (NVO) position steady in Q2 2026 at 8,711 shares worth $418K. The position accounts for 0.15% of the portfolio, ranked #99.

1776 Wealth first reported a position in NVO in Q3 2025 and has held it in 4 quarters since. The position peaked at $473K in Q3 2025. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • 1776 Wealth held 8,711 shares of Novo Nordisk worth $418K as of Q2 2026.
  • 1776 Wealth left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up 0.15% of 1776 Wealth's portfolio in Q2 2026, its #99 holding.
  • 1776 Wealth first reported a position in Novo Nordisk in Q3 2025 and has held it in 4 quarters since.
  • 1776 Wealth's Novo Nordisk position peaked at $473K in Q3 2025.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on 1776 Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.